2026-04-18T04:30:47Zhttps://recercat.cat/oai/request

oai:recercat.cat:2445/1862022025-12-05T04:24:22Zcom_2072_1057col_2072_478809col_2072_478917

Direct medical costs of non-alcoholic fatty liver disease in Catalonia at the hospital level: a retrospective multicenter study Darbà, Josep Tractament de l'alcoholisme Política sanitària Cost de l'assistència sanitària Alcoholism treatment Medical policy Cost of medical care The prevalence of non-alcoholic fatty liver disease (NAFLD) is increasing worldwide, which is expected to correlate with significant medical and social costs. This study aimed to evaluate the clinical and economic burden of NAFLD in Catalonia at the hospital level. 2022-06-02T12:13:47Z 2023-03-01T06:10:27Z 2022-03-01 2022-06-02T12:13:47Z info:eu-repo/semantics/article info:eu-repo/semantics/acceptedVersion 1473-7167 https://hdl.handle.net/2445/186202 707001 eng Versió postprint del document publicat a: https://doi.org/10.1080/14737167.2021.1890586 Expert Review of Pharmacoeconomics & Outcomes Research, 2022, vol. 22, num. 2, p. 341-349 https://doi.org/10.1080/14737167.2021.1890586 (c) Informa Healthcare, 2022 info:eu-repo/semantics/openAccess 9 p. application/pdf Informa Healthcare Articles publicats en revistes (Economia)